A Wonder Drug in the Arsenal against COVID - 19: Medication Evidence from Ivermectin
B. Suresh Kumar, Madhan Jeyaraman, Rashmi Jain & Talagavadi Channaiah Anudeep · Journal of Advances in Medicine and Medical Research · 2020
Ivermectin, an FDA approved broad-spectrum anti-parasitic agent has been recently reported to show an inhibitory activity against SARS-CoV-2 in an in-vitro study. This antiviral response has rendered it as a potential drug to be repurposed for COVID-19. Previously, ivermectin had...
Open access
Research Article
10.9734/jammr/2020/v32i1030512